Canada markets open in 8 hours 58 minutes

Centessa Pharmaceuticals plc (260.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
8.50-0.05 (-0.58%)
At close: 03:29PM CEST
Currency in EUR

Valuation Measures4

Market Cap (intraday) 929.14M
Enterprise Value 769.62M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)128.60
Price/Book (mrq)4.33
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA 1.05

Trading Information

Stock Price History

Beta (5Y Monthly) 1.45
52-Week Change 3107.32%
S&P500 52-Week Change 326.27%
52 Week High 311.20
52 Week Low 33.82
50-Day Moving Average 39.39
200-Day Moving Average 37.17

Share Statistics

Avg Vol (3 month) 34
Avg Vol (10 day) 3N/A
Shares Outstanding 5111.66M
Implied Shares Outstanding 6116.86M
Float 849.38M
% Held by Insiders 12.07%
% Held by Institutions 175.01%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-513.32%

Management Effectiveness

Return on Assets (ttm)-26.61%
Return on Equity (ttm)-52.79%

Income Statement

Revenue (ttm)6.85M
Revenue Per Share (ttm)0.07
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -170.97M
Net Income Avi to Common (ttm)-151.08M
Diluted EPS (ttm)-1.46
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)256.55M
Total Cash Per Share (mrq)2.56
Total Debt (mrq)85.09M
Total Debt/Equity (mrq)36.02%
Current Ratio (mrq)8.00
Book Value Per Share (mrq)2.39

Cash Flow Statement

Operating Cash Flow (ttm)-160.34M
Levered Free Cash Flow (ttm)-97.11M